Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy
Yifan Zhao(Unknown), Mingfeng Zhao(Nankai University), Haibo Zhu(Tianjin First Center Hospital), Cuicui Lyu(Tianjin First Center Hospital), Ruiting Guo(Tianjin Medical University), Xiaoyuan He(Tianjin First Center Hospital), Yi Zhang(Tianjin Medical University General Hospital), Meng Zhang(Scripps Research Institute), Xia Xiao(Hebei Medical University), Yu Zhang(Shantou University), Yedi Pu(Tianjin First Center Hospital), Pengjiang Liu(Tianjin First Center Hospital), Xiaomei Zhang(Tang Hospital), Hairong Lyu(Tianjin First Center Hospital)
Cited by 32
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k